Skip to main navigation Skip to search Skip to main content

Extubation in neurocritical care patients: the ENIO international prospective study

  • on behalf of the ENIO Study Group, the PROtective VENTilation network, the European Society of Intensive Care Medicine, the Colegio Mexicano de Medicina Critica, the Atlanréa group and the Société Française d’Anesthésie-Réanimation–SFAR research network
  • Nantes Université
  • Universidad de Guadalajara
  • IRCCS Ospedale Policlinico San Martino
  • University of Genoa
  • University of Bern
  • Sanjay Gandhi Postgraduate Institute of Medical Sciences
  • Amsterdam University Medical Center
  • Mahidol University
  • University of Oxford
  • NHS Grampian
  • Sanatorio Pasteur, Argentina
  • Hospital Maciel Montevideo
  • Department of Critical Care Medicine of Asklepieio G.H.A
  • Tokushima University
  • Hospital Clinico Universitario de Valencia
  • Hamad Medical Corporation
  • Université libre de Bruxelles
  • University of Tripoli
  • Dhaka Medical College Hospital
  • Cairo University
  • Toronto Western Hospital
  • Johns Hopkins University
  • University of California at San Francisco

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: Neurocritical care patients receive prolonged invasive mechanical ventilation (IMV), but there is poor specific information in this high-risk population about the liberation strategies of invasive mechanical ventilation. Methods: ENIO (NCT03400904) is an international, prospective observational study, in 73 intensive care units (ICUs) in 18 countries from 2018 to 2020. Neurocritical care patients with a Glasgow Coma Score (GCS) ≤ 12, receiving IMV ≥ 24 h, undergoing extubation attempt or tracheostomy were included. The primary endpoint was extubation failure by day 5. An extubation success prediction score was created, with 2/3 of patients randomly allocated to the training cohort and 1/3 to the validation cohort. Secondary endpoints were the duration of IMV and in-ICU mortality. Results: 1512 patients were included. Among the 1193 (78.9%) patients who underwent an extubation attempt, 231 (19.4%) failures were recorded. The score for successful extubation prediction retained 20 variables as independent predictors. The area under the curve (AUC) in the training cohort was 0.79 95% confidence interval (CI95) [0.71–0.87] and 0.71 CI95 [0.61–0.81] in the validation cohort. Patients with extubation failure displayed a longer IMV duration (14 [7–21] vs 6 [3–11] days) and a higher in-ICU mortality rate (8.7% vs 2.4%). Three hundred and nineteen (21.1%) patients underwent tracheostomy without extubation attempt. Patients with direct tracheostomy displayed a longer duration of IMV and higher in-ICU mortality than patients with an extubation attempt (success and failure). Conclusions: In neurocritical care patients, extubation failure is high and is associated with unfavourable outcomes. A score could predict extubation success in multiple settings. However, it will be mandatory to validate our findings in another prospective independent cohort.

Original languageEnglish
Pages (from-to)1539-1550
Number of pages12
JournalIntensive Care Medicine
Volume48
Issue number11
DOIs
Publication statusPublished - 29 Aug 2022

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Keywords

  • Brain injury
  • Extubation
  • Intra-cranial haemorrhage
  • Tracheostomy
  • Traumatic brain injury

Fingerprint

Dive into the research topics of 'Extubation in neurocritical care patients: the ENIO international prospective study'. Together they form a unique fingerprint.

Cite this